Purple Biotech Ltd. (PPBT)
NASDAQ: PPBT
· Real-Time Price · USD
2.43
0.12 (5.19%)
At close: Aug 15, 2025, 3:59 PM
2.28
-6.17%
After-hours: Aug 15, 2025, 04:48 PM EDT
Purple Biotech Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -3.95M | -7.28M | -11.72M | -16.11M | -18.86M | -19.98M | -21.16M | -20.96M | -19.35M | -21.76M | -20.47M | -18.48M | -18.71M | -17.83M | -13.07M | -10.21M | -6.45M |
Depreciation & Amortization | 183K | 186K | 194K | 195K | 199K | 197K | 199K | 197K | 196K | 201K | 212K | 227K | 236K | 231K | 170.07K | 107.14K | 46.19K |
Stock-Based Compensation | 409K | 582K | 797K | 1.11M | 1.39M | 1.88M | 2.53M | 2.79M | 2.85M | 2.41M | 1.88M | 1.56M | 1.68M | 2.08M | 1.78M | 1.39M | 712.27K |
Other Working Capital | -1.49M | -1.37M | -679.88K | 74.12K | 929.12K | -1.06M | 1.04M | -431K | -1.13M | 3.59M | 2.46M | 3.2M | 796K | 814K | -291.18K | -109.3K | 2.75M |
Other Non-Cash Items | -3.79M | -3.52M | -4.33M | -3.56M | -2.76M | -2.29M | -1.44M | -984K | -1.05M | -843K | -482K | -461K | -244K | -482K | -289.45K | -82.97K | -250.67K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -210K | -374K | -219K | -374K | -164K | n/a | -155K |
Change in Working Capital | -4.11M | -4.33M | -2.27M | 663K | 1.08M | 274K | 716K | -170K | -256K | 3.25M | 2.59M | 1.56M | 63K | 744K | -86.18K | 236.7K | 2.45M |
Operating Cash Flow | -11.26M | -14.37M | -17.34M | -17.7M | -18.94M | -19.93M | -19.16M | -19.12M | -17.6M | -16.73M | -16.27M | -15.59M | -16.97M | -15.25M | -11.5M | -8.57M | -3.49M |
Capital Expenditures | n/a | n/a | n/a | 1K | n/a | -3K | -3K | -9K | -14K | -228K | -228K | -229K | -305K | -115K | -115.08K | -109.08K | -27.08K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | -3.55M | -3.55M | -3.55M | -3.55M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 34.50 |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1K | 1K | 1K | 1.95M | n/a | n/a | n/a | -1.95M | n/a | n/a |
Sales Maturities Of Investments | 223K | 189K | 183K | 1.06M | 1.06M | 16.68M | 24.68M | 23.8M | 20.3M | 22.3M | 17.35M | 20.7M | 29.66M | 13.16M | 10.11M | 6.77M | 1.3M |
Other Investing Acitivies | 231K | 195.31K | 237.31K | 289.31K | 403.31K | 755K | 683K | 737K | -1.93M | -2.15M | -2.1M | -2.1M | 452K | 359K | 272.23K | 65.38K | -9.61K |
Investing Cash Flow | 454K | 509K | 545K | 1.48M | 1.59M | 13.88M | 21.81M | 20.98M | 14.8M | 19.91M | 16.97M | 18.37M | 29.81M | 13.41M | 8.32M | 6.72M | 1.26M |
Debt Repayment | -191K | -183K | -177K | -175K | -171K | -168K | -167K | -166K | -165K | -165K | -165K | -163K | -159K | -153K | -112K | -73K | -36K |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 1.14M | 1.15M | 5.81M | 4.07M | 4.08M | 4.05M | -286K | -271K | -282K | -219K | -207K | -176K | -106K | 1.1M | 1.15M | 1.17M | 1.22M |
Financial Cash Flow | 6.61M | 6.77M | 7.08M | 5.52M | 5.45M | 5.45M | 1.29M | 1.29M | 1.22M | 1.11M | 1.5M | 878K | 529K | 1.51M | 1.04M | 1.1M | 1.18M |
Net Cash Flow | -4.21M | -7.09M | -9.67M | -10.68M | -11.9M | -541K | 4.03M | 3.2M | -1.65M | 4.14M | 1.96M | 3.47M | 13.34M | -357K | -2.16M | -758.75K | -1.07M |
Free Cash Flow | -11.26M | -14.37M | -17.34M | -17.7M | -18.94M | -19.93M | -19.16M | -19.13M | -17.61M | -16.96M | -16.5M | -15.82M | -17.28M | -15.37M | -11.62M | -8.67M | -3.51M |